Invention Grant
US07323460B2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors
失效
可用作HIV整合酶抑制剂的N-(取代苄基)-8-羟基-1,6-萘啶-7-甲酰胺
- Patent Title: N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors
- Patent Title (中): 可用作HIV整合酶抑制剂的N-(取代苄基)-8-羟基-1,6-萘啶-7-甲酰胺
-
Application No.: US10508094Application Date: 2003-03-12
-
Publication No.: US07323460B2Publication Date: 2008-01-29
- Inventor: Melissa Egbertson , H. Marie Langford , Jeffrey Y. Melamed , John S. Wai , Wei Han , Debbie S. Perlow , Linghang Zhuang , Mark Embrey
- Applicant: Melissa Egbertson , H. Marie Langford , Jeffrey Y. Melamed , John S. Wai , Wei Han , Debbie S. Perlow , Linghang Zhuang , Mark Embrey
- Applicant Address: US NJ Rahway
- Assignee: Merck & Co., Inc.
- Current Assignee: Merck & Co., Inc.
- Current Assignee Address: US NJ Rahway
- Agent Kenneth R. Walton; Sheldon O. Heber
- International Application: PCT/US03/07448 WO 20030312
- International Announcement: WO03/077850 WO 20030925
- Main IPC: C07D401/02
- IPC: C07D401/02 ; A61K31/4375

Abstract:
N-(Substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides are inhibitors of HIV integrase and inhibitors of HIV replication. The naphthyridine carboxamides are of Formula (I): wherein R1′, R2′ and R3′ are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are described.
Public/Granted literature
- US20050176955A1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors Public/Granted day:2005-08-11
Information query